High-fat diet/low-dose streptozotocin-induced type 2 diabetes in rats impacts osteogenesis and Wnt signaling in bone marrow stromal cells

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Qian, Chao ^a   Zhu, Chenyuan ^a   Yu, Weiqiang ^a   Jiang, Xinquan ^a   Zhang, Fuqiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE CEMENT; CALCIUM PHOSPHATE CEMENT; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; STREPTOZOCIN; UNCLASSIFIED DRUG; WNT PROTEIN; CALCIUM PHOSPHATE; CCND1 PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, MOUSE; GSK3B PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE IMPLANT; BONE MARROW STROMA CELL; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; GENE EXPRESSION; LIPID DIET; MINERALIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; WNT SIGNALING PATHWAY; ADVERSE EFFECTS; ANIMAL; BONE MARROW CELL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT; XENOGRAFT;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CALCIUM PHOSPHATES; CYCLIN D1; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; OSTEOGENESIS; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TRANSPLANTATION, HETEROLOGOUS; WNT SIGNALING PATHWAY;

EID: 84942877317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136390     Document Type: Article

References (53)

1. Dominguez LJ, Muratore M, Quarta E, Zagone G, Barbagallo M. Osteoporosis and diabetes. Reuma-tismo 2004;56:235-241. PMID: 15643475
2. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes melli-tus and risk of fracture. Am J Epidemiol 2007;166:495-505. PMID: 17575306
3. Duarte Vr MG, Ramos AMO, Rezende LA, Macedo UBO, Brandao-Neto J, Almeida MG, et al. Osteopenia: a bone disorder associated with diabetes mellitus. Journal of Bone and Mineral Metabolism 2005;23:58-68. PMID: 15616896
4. Del Pino-Montes J, Benito GE, Fernández-Salazar MP, Coveñas R, Calvo JJ, Bouillon R, et al. Calci-triol Improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcified Tissue International 2004;75:526-532. PMID: 15654497
5. Musumeci G, Loreto C, Clementi G, Fiore CE, Martinez G. An in vivo experimental study on osteopenia in diabetic rats. Acta Histochemica 2011;113:619-625. doi: 10.1016/j.acthis.2010.07.002 PMID: 20696468
6. Erdal N, Gürgül S, Kavak S, Yildiz A, Emre M. Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats. Biological Trace Element Research 2010;140:342-353. doi: 10.1007/s12011-010-8703-4 PMID: 20446056
7. Kim JH, Lee DE, Choi SH, Cha JH, Bak EJ, Yoo YJ. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis. Journal of Periodontal Research 2014;49:792-800. doi: 10.1111/jre.12165 PMID: 24490978
8. Yaturu S. Diabetes and skeletal health. J diabetes 2009;1:246-254. doi: 10.1111/j.1753-0407.2009. 00049.x PMID: 20923525
9. Fajardo RJ, Karim L, Calley VI, Bouxsein ML. A review of rodent models of type 2 diabetic skeletal fragility. Journal of Bone and Mineral Research 2014;29:1025-1040. doi: 10.1002/jbmr.2210 PMID: 24585709
10. Milner PI, Clegg PD, Stewart MC. Stem cell-based therapies for bone repair. Veterinary Clinics of North America: Equine Practice 2011;27:299-314. doi: 10.1016/j.cveq.2011.05.002 PMID: 21872760
11. Mauney JR, Volloch V, Kaplan DL. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 2005;11:787-802. PMID: 15998219
12. Khosla S, Westendorf JJ, Mödder UI. Concise review: insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem cells 2010;28:2124-2128. doi: 10.1002/stem.546 PMID: 20960512
13. Lian Z, Yin X, Li H, Jia L, He X, Yan Y, et al. Synergistic effect of bone marrow-derived mesenchymal stem cells and platelet-rich plasma in streptozotocin-induced diabetic rats. Annals of Dermatology 2014;26:1-10. doi: 10.5021/ad.2014.26.1.1 PMID: 24648680
14. Zhong QL, Liu FR, Liu DW, Peng Y, Zhang XR. Expression of (5-catenin and cyclin D1 in epidermal stem cells of diabetic rats. Molecular Medicine Reports 2011;4:377-381. doi: 10.3892/mmr.2011.435 PMID: 21468580
15. Tolosa MJ, Chuguransky SR, Sedlinsky C, Schurman L, McCarthy AD, Molinuevo MS, et al. Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin. Diabetes Research and Clinical Practice 2013;101:177-186. doi: 10.1016/j.diabres.2013.05.016 PMID: 23806481
16. Pan XH, Song QQ, Dai JJ, Yao X, Wang JX, Pang RQ, et al. Transplantation of bone marrow mesenchymal stem cells for the treatment of type 2 diabetes in a macaque model. Cells Tissues Organs 2013;198:414-427. doi: 10.1159/000358383 PMID: 24686078
17. Yu M, Zhou W, Song Y, Yu F, Li D, Na S, et al. Development of mesenchymal stem cell-implant complexes by cultured cells sheet enhances osseointegration in type 2 diabetic rat model. Bone 2011;49:387-394. doi: 10.1016/j.bone.2011.05.025 PMID: 21672646
18. Zhao YF, Zeng DL, Xia LG, Zhang SM, Xu LY, Jiang XQ et al. Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats. International Journal of Molecular Medicine 2013;31:614-620. doi: 10.3892/ijmm.2013.1227 PMID: 23292283
19. Yang Y, Mallampati S, Sun B, Zhang J, Kim SB, Lee JS, et al. Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target. Cancer Letters 2013;333:9-17. doi: 10.1016/j.canlet.2012.11.056 PMID: 23333798
20. Hoeppner LH, Secreto FJ, Westendorf JJ. Wnt signaling as a therapeutic target for bone diseases. Expert OpinTherTargets 2009;13:485-496. doi: 10.1517/14728220902841961 PMID: 19335070
21. Galli C, Piemontese M, Lumetti S, Manfredi E, Macaluso GM, Passeri G. The importance of WNT pathways for bone metabolism and their regulation by implant topography. Eur Cell Mater 2012;24:46-59. PMID: 22791372
22. Chen Y, Alman BA. Wnt pathway, an essential role in bone regeneration. J Cell Biochem 2009;106:353-362. doi: 10.1002/jcb.22020 PMID: 19127541
23. Kim JB, Leucht P, Lam K, Luppen C, Ten Berge D, Nusse R, et al. Bone regeneration is regulated by wnt signaling. J Bone Miner Res 2007;22:1913-1923. PMID: 17696762
24. Chung R, Wong D, Macsai C, Piergentili A, Del Bello F, Quaglia W, et al. Roles of Wnt/p-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats. Bone 2013;52:651-658. doi: 10.1016/j.bone.2012.10.035 PMID: 23149278
25. Arioka M, Takahashi-Yanaga F, Sasaki M, Yoshihara T, Morimoto S, Takashima A, et al. Acceleration of bone development and regeneration through the Wnt/p-catenin signaling pathway in miceheterozy-gously deficient for GSK-3p. Biochem Biophys Res Commun 2013;440:667-682.
26. Minear S, Leucht P, Jiang J, Liu B, Zeng A, Fuerer C, et al. Wnt proteins promote bone regeneration. SciTransl Med 2010;2:29ra30. doi: 10.1126/scitranslmed.3000231 PMID: 20427820
27. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose strep-tozotocin induced type 2 diabetes rat model. Experimental Diabetes Research 2008;2008:1-9.
28. Liu Z, Li W, Li X, Zhang M, Chen L, Zheng YN, et al. Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. Journal of Ethno-pharmacology 2013;145:233-40. doi: 10.1016/j.jep. 2012.10.058 PMID: 23147499
29. Jiang X, Zhao J, Wang S, Sun X, Zhang X, Chen J, et al. Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials 2009;30:4522-4532. doi: 10.1016/j. biomaterials.2009.05.021 PMID: 19501905
30. Zhang Y, Yu W, Jiang X, Lv K, Sun S, Zhang F. Analysis of the cytotoxicity of differentially sized titanium dioxide nanoparticles in murine MC3T3-E1 preosteoblasts. Journal of Materials Science: Materials in Medicine 2011;22:1933-1945. doi: 10.1007/s10856-011-4375-7 PMID: 21681655
31. Zhang W, Wang G, Liu Y, Zhao X, Zou D, Zhu C, et al. The synergistic effect of hierarchical micro/nano-topography and bioactive ions for enhanced osseointegration. Biomaterials 2013;34:3184-3195. doi: 10.1016/j.biomaterials.2013.01.008 PMID: 23380352
32. Xia L, Zhang M, Chang Q, Wang L, Zeng D, Zhang X et al. Enhanced Dentin-Like Mineralized Tissue Formation by AdShh-Transfected Human Dental Pulp Cells and Porous Calcium Phosphate Cement. PLoS ONE 2013;8:e62645. doi: 10.1371/journal.pone.0062645 PMID: 23675415
33. Kuo YR, Wang CT, Cheng JT, Wang FS, Chiang YC, Wang CJ. Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. Plastic and Reconstructive Surgery 2011;128:872-880. doi: 10. 1097/PRS.0b013e3182174329 PMID: 21921763
34. Zhang W, Li Z, Huang Q, Ling X, Li J, Jin Y et al. Effects of a hybrid micro/nanorod topography-modified titanium implant on adhesion and osteogenic differentiation in rat bone marrow mesenchymal stem cells. International Journal of Nanomedicine 2013;8:257-265. doi: 10.2147/IJN. S39357 PMID: 23345973
35. Hamann C, Goettsch C, Mettelsiefen J, Henkenjohann V, Rauner M, Hempel U, et al. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab 2011;301:E1220-1228. doi: 10.1152/ajpendo.00378.2011 PMID: 21900121
36. Korres N, Tsiridis E, Pavlou G, Mitsoudis A, Perrea DN, Zoumbos AB. Biomechanical characteristics of bone in streptozotocin-induced diabetic rats: Anin-vivorandomized controlled experimental study. World Journal of Orthopedics 2013;4:124-129. doi: 10.5312/wjo.v4.i3.124 PMID: 23878780
37. Hie M, Iitsuka N, Otsuka T, Tsukamoto I. Insulin-dependent diabetes mellitus decreases osteoblasto-genesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. International Journal of Molecular Medicine 2011;28:455-462. doi: 10. 3892/ijmm.2011.697 PMID: 21567076
38. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000;49:1390-1394. PMID: 11092499
39. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-320. PMID: 15979893
40. Jin P, Zhang X, Wu Y, Li L, Yin Q, Zheng L, et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010;42:2745-2752. doi: 10.1016/j.transproceed.2010.05.145 PMID: 20832580
41. Xu L, Sun X, Cao X, Wu Y, Zou D, Liu Y, et al. Hypoxia induces osteogenesis in rabbit adipose-derived stem cells overexpressing bone morphogenic protein-2. Oral Diseases 2014;20:430-439. doi: 10. 1111/odi.12148 PMID: 23865899
42. Lü K, Xu L, Xia L, Zhang Y, Zhang X, Kaplan DL, et al. An ectopic study of apatite-coated silk fibroin scaffolds seeded with adBMP-2-modified canine bMSCs. J BiomaterSci Polym Ed 2012;23:509-526. doi: 10.1163/092050610X552861 PMID: 21294971
43. Cao Z, Liu R, Zhang H, Liao H, Zhang Y, Hinton RJ, et al. Osterixcontrols cementoblastdifferentiation through downregulationof Wnt-signaling via enhancing DKK1 Expression. Int J Biol Sci 2015;5:335-344.
44. Zhang W, Li Z, Liu Y, Ye D, Li J, Xu L, et al. Biofunctionalization of a titanium surface with a nano-saw-tooth structure regulates the behavior of rat bone marrow mesenchymal stem cells. International Journal of Nanomedicine 2012;7:4459-4472. doi: 10.2147/IJN. S33575 PMID: 22927760
45. Retzepi M, Donos N. The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res 2010;21:673-681. doi: 10.1111/j.1600-0501.2010.01923.x PMID: 20465554
46. Leucht P, Helms JA. Wnt signaling: an emerging target for bone regeneration. J Am Acad Orthop Surg 2015;23:67-68. doi: 10.5435/JAAOS-23-01-67 PMID: 25538132
47. Secreto FJ, Hoeppner LH, Westendorf JJ. Wnt signaling during fracture repair. CurrOsteoporos Rep 2009;7:64-69. PMID: 19631031
48. Tang Y, Zhou X, Gao B, Xu X, Sun J, Cheng L, et al. Modulation of Wnt/p-catenin signaling attenuates periapical bone lesions. J Dent Res 2014;93:175-182. doi: 10.1177/0022034513512507 PMID: 24211867
49. Leng S, Zhang W, Zheng Y, Liberman Z, Rhodes CJ, Eldar-Finkelman H, et al. Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1. J Endocrinol 2010;206:171-181. doi: 10.1677/JOE-09-0456 PMID: 20466847
50. Zheng T, Yang X, Wu D, Xing S, Bian F, Li W, et al. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3p pathway. Br J Pharmacol 2015; Mar. 5. doi: 10.1111
51. Sun TJ, Tao R, Han YQ, Xu G, Liu J, Han YF. Therapeutic potential of umbilical cord mesenchymal stem cells with Wnt/beta-catenin signaling pathway pre-activated for the treatment of diabetic wounds. Eur Rev Med Pharmacol Sci 2014;18:2460-2464. PMID: 25268090
52. Hofmann A, Mattyasovszky SG, Brüning C, Ritz U, Mehling I, Meurer A, et al. Osteoblasts: cellular and molecular regulatory mechanisms in fracture healing. Orthopade 2009;38:1009-1019. doi: 10.1007/s00132-009-1488-5 PMID: 19826779
53. Chong ZZ, Shang YC, Maiese K. Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr Neurovasc Res 2007;4:194-204. PMID: 17691973